Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neutralizing antibody response and SARS severity.

Mei-Shang Ho1, Wei-Ju Chen, Hour-Young Chen

  • 1Academia Sinica, Taipei, Taiwan.

Emerging Infectious Diseases
|December 2, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interactive effects of retinal biomarkers and sleep on cognition: longitudinal evidence from community-dwelling older adults.

GeroScience·2026
Same author

Erratum for Hsu et al., "Evaluating the susceptibility of various common cell lines and assessing inactivation conditions to Mpox virus".

Microbiology spectrum·2026
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Drug Development.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Public Health.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Public Health.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same journal

Detection of and Early Genomic Insights into Chikungunya Virus, Bolivia, 2025.

Emerging infectious diseases·2026
Same journal

Household Transmission of Enterovirus D68, Washington and Oregon, United States, 2022-2024.

Emerging infectious diseases·2026
Same journal

New World Ocular Dirofilariasis Caused by Dirofilaria repens Infection, United States.

Emerging infectious diseases·2026
Same journal

Angiostrongylus cantonensis Rat Lungworm Detected in Rats, Madagascar, 2022-2023.

Emerging infectious diseases·2026
Same journal

Human Pulmonary Dirofilariasis,
North Queensland, Australia, 2023<sup>1</sup>.

Emerging infectious diseases·2026
Same journal

Trends in Congenital Syphilis Cases by Maternal Country of Birth, Spain, 2016-2024.

Emerging infectious diseases·2026
See all related articles

Early severe acute respiratory syndrome (SARS) neutralizing antibody responders had a higher mortality rate and shorter survival. This suggests a link between rapid antibody development and poorer clinical outcomes in SARS patients.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Epidemiology

Background:

  • Severe acute respiratory syndrome (SARS) is a significant global health concern.
  • Understanding the immune response, particularly neutralizing antibodies, is crucial for managing SARS.
  • The relationship between antibody kinetics and clinical outcomes in SARS requires further elucidation.

Purpose of the Study:

  • To analyze the dynamics of neutralizing antibodies in relation to clinical outcomes in SARS patients.
  • To investigate the implications of early versus delayed antibody responses on SARS patient prognosis.
  • To inform SARS pathogenesis understanding and vaccine development strategies.

Main Methods:

  • Utilized a Taiwan nationwide laboratory-confirmed SARS database.

Related Experiment Videos

  • Employed a linear mixed model to analyze neutralizing antibody titers over time.
  • Applied Fisher exact tests to compare clinical outcomes between early and delayed antibody responders.

    • Main Results:

    • Neutralizing antibody titers peaked 5-8 weeks post-onset, with a half-life of 6.4 weeks.
    • Longer illness duration correlated with a lower neutralizing antibody response (p = 0.008).
    • Early responders (within 2 weeks) exhibited higher mortality (29.6% vs. 7.8%, p = 0.004) and shorter survival (<2 weeks, p = 0.013).

    Conclusions:

    • Early neutralizing antibody response in SARS is associated with adverse clinical outcomes, including increased mortality.
    • Findings suggest a complex relationship between immune response timing and disease severity in SARS.
    • This research provides critical insights for SARS vaccine development and understanding disease pathogenesis.